Amanda Fosang

ORCID: 0000-0002-5523-5427
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Osteoarthritis Treatment and Mechanisms
  • Cell Adhesion Molecules Research
  • Protease and Inhibitor Mechanisms
  • Proteoglycans and glycosaminoglycans research
  • Inflammatory mediators and NSAID effects
  • Peptidase Inhibition and Analysis
  • Blood Coagulation and Thrombosis Mechanisms
  • Glycosylation and Glycoproteins Research
  • Connective tissue disorders research
  • Knee injuries and reconstruction techniques
  • Immune Response and Inflammation
  • Fibroblast Growth Factor Research
  • Chemokine receptors and signaling
  • Spine and Intervertebral Disc Pathology
  • Lower Extremity Biomechanics and Pathologies
  • Cytokine Signaling Pathways and Interactions
  • Collagen: Extraction and Characterization
  • Neonatal Respiratory Health Research
  • TGF-β signaling in diseases
  • Periodontal Regeneration and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Bone Metabolism and Diseases
  • Pregnancy-related medical research
  • Signaling Pathways in Disease
  • Chemical Synthesis and Analysis

Murdoch Children's Research Institute
2010-2019

Royal Children's Hospital
2010-2019

The University of Melbourne
2010-2019

The University of Sydney
2010-2016

Knowledge Unlatched (Germany)
2015

Shura Council
2015

Milbank Memorial Fund
2014

Royal North Shore Hospital
2010

Orthopaedic Research
2003

The Royal Melbourne Hospital
1991-1995

Proteoglycans are produced by most eukaryotic cells and versatile components of pericellular extracellular matrices. They belong to many different protein families. Their functions vary from the physical effects proteoglycan aggrecan, which binds with link hyaluronan form multi-molecular aggregates in cartilage; intercalated membrane CD44 that has a is receptor cell-binding site for hyaluronan; heparan sulfate proteoglycans syndecan other families provide matrix binding sites cell-surface...

10.1096/fasebj.6.3.1740236 article EN The FASEB Journal 1992-02-01

Abstract Objective To investigate the role of matrix metalloproteinase 13 (MMP‐13; collagenase 3) in osteoarthritis (OA). Methods OA was surgically induced knees MMP‐13–knockout mice and wild‐type mice, were compared. Histologic scoring femoral tibial cartilage aggrecan loss (0–3 scale), erosion (0–7 chondrocyte hypertrophy (0–1 as well osteophyte size scale) maturity performed. Serial sections stained for type X collagen MMP‐generated neoepitope DIPEN. Results Following surgery, more severe...

10.1002/art.25002 article EN Arthritis & Rheumatism 2009-11-30

The assembly and degradation of extracellular matrix (ECM) molecules are crucial processes during bone development. In this study, we show that ECM remodeling is a critical rate-limiting step in endochondral formation. Matrix metalloproteinase (MMP) 13 (collagenase 3) poised to play role formation because its expression both terminal hypertrophic chondrocytes the growth plate osteoblasts. Moreover, mutation human MMP13 gene causes Missouri variant spondyloepimetaphyseal dysplasia....

10.1242/dev.01461 article EN Development 2004-11-11

Degradation of the large cartilage proteoglycan aggrecan in arthritis involves an unidentified enzyme aggrecanase, and at least one matrix metalloproteinases. Proteinase-sensitive cleavage sites interglobular domain (IGD) have been identified for many humman MMPs, as well aggrecanase other proteinases. The major MMP expressed by chondrocytes stimulated with retinoic acid to degrade their is collagenase-3 or MMP-13. Because its potential role degradation we examined specificity MMP-13...

10.1016/0014-5793(95)01539-6 article EN FEBS Letters 1996-02-12

The action of three matrix metalloproteinases (MMPs), 72- and 95-kDa gelatinases (MMP-2 MMP-9) PUMP (MMP-7), a cysteine proteinase, cathepsin B, were investigated on aggrecan the major proteoglycan cartilage. All enzymes cleaved although activity gelatinase was very low. Specific cleavage sites following incubation with purified G1-G2 domain fragment (150 kDa). Both produced 110-kDa G2 56-kDa G1 products by single at an Asn-Phe bond within interglobular close to domain. This similar...

10.1016/s0021-9258(18)41799-1 article EN cc-by Journal of Biological Chemistry 1992-09-01

Monoclonal antibodies have been prepared that react specifically with the neoepitopes present on proteoglycan degradation products generated from proteolytic cleavage of aggrecan in interglobular domain. Antibody BC-3 recognizes new N-terminus (ARGSV...) produced by action as yet uncharacterized activity, 'aggrecanase', and antibody BC-4 C-terminus (...DIPEN) matrix metalloproteinases. Specificity for these neoepitope sequences was determined competitive e.l.i.s.a. using synthetic peptide...

10.1042/bj3050799 article EN Biochemical Journal 1995-02-01

Proteolytic degradation of aggrecan is a hallmark the pathology arthritis, yet identity enzyme(s) in cartilage responsible for this unknown. Previous studies have suggested that matrix metalloproteinases (MMPs) may be involved but there has been no definitive evidence their direct action proteolysis human arthritis. We now show unequivocally fragments derived from specific MMPs can detected synovial fluids patients with both inflammatory and noninflammatory neoepitope monoclonal antibody...

10.1172/jci119040 article EN Journal of Clinical Investigation 1996-11-15

Aggrecan loss from cartilage in arthritis is mediated by aggrecanases. Aggrecanases cleave aggrecan preferentially the chondroitin sulfate-2 (CS-2) domain and secondarily at E(373) downward arrow(374)A bond interglobular (IGD). However, IGD cleavage may be more deleterious for biomechanics because it releases entire CS-containing portion of aggrecan. Recent studies identifying aggrecanase-2 (ADAMTS-5) as predominant aggrecanase mouse have not distinguished aggrecanolysis CS-2 domain. We...

10.1172/jci30765 article EN Journal of Clinical Investigation 2007-05-18

Abstract Introduction Physiological and pathophysiological cartilage turnover may coexist in articular cartilage. The distinct enzymatic processes leading to irreversible damage, compared with those needed for continuous self-repair regeneration, remain be identified. We investigated the capacity of repair chondrocytes by analyzing their ability initiate an anabolic response subsequent three different levels catabolic stimulation. Methods Cartilage degradation was induced oncostatin M tumour...

10.1186/ar2434 article EN cc-by Arthritis Research & Therapy 2008-05-30

A workshop held last June by the National Institutes of Health (NIH) Director's Office, Nature Publishing Group, and Science focused on role that journals play in supporting scientific research is reproducible, robust, transparent. The "Principles Guidelines for Reporting Preclinical Research" (http://www.nih.gov/research-training/rigor-reproducibility/principles-guidelines-reporting-preclinical-research) emerged from have since been endorsed nearly 80 societies, journals, associations.

10.1074/jbc.e115.000002 article EN cc-by Journal of Biological Chemistry 2015-12-01

Pain is the predominant symptom of osteoarthritis, but connection between joint damage and genesis pain not well understood. Loss articular cartilage a hallmark it occurs through enzymatic degradation aggrecan by cleavage mediated disintegrin metalloproteinase with thrombospondin motif 4 (ADAMTS-4) or ADAMTS-5 in interglobular domain (E373–374A). Further MMPs (N341–342F) releases 32-amino-acid fragment (32-mer). We investigated role this 32-mer driving pain. found that excites dorsal root...

10.1172/jci.insight.95704 article EN JCI Insight 2018-03-21

Normal and pathological turnover of proteoglycans in articular cartilage involves its cleavage close to the N-terminal G1 domain responsible for aggregation. A fragment containing G2 domains pig was therefore used as a substrate investigate degradation by metalloproteinase stromelysin related recombinant enzymes. The stromelysins produced an apparent single yielding 56 kDa 110 kDa. Rabbit bone much more active against G1-G2 proteoglycan aggregates than human stromelysin-1 stromelysin-2. All...

10.1016/s0021-9258(18)98442-5 article EN cc-by Journal of Biological Chemistry 1991-08-01

The actions of recombinant human fibroblast collagenase (MMP1), purified polymorphonuclear leucocyte (MMP8) and their N-terminal catalytic domain fragments against cartilage aggrecan an G1-G2 fragment have been investigated in vitro. After activation with stromelysin typsin, both collagenases were able to degrade porcine aggrecans a similar extent. An (150 kDa) was used identify specific cleavage sites occurring within the proteinase-sensitive interglobular between G1 G2. Two found; one at...

10.1042/bj2950273 article EN Biochemical Journal 1993-10-01

To determine whether an aggrecan 32-mer fragment derived from dual ADAMTS and matrix metalloproteinase (MMP) cleavage in the interglobular domain was bioactive and, if so, to elucidate its mechanism of action.Mouse primary chondrocytes, synovial fibroblasts, or peritoneal macrophages, human cells cell lines myeloid differentiation factor 88 (MyD88)-deficient Toll-like receptor 2 (TLR-2)-deficient mice were stimulated with synthetic mouse peptide, a scrambled native, glycosylated peptide....

10.1002/art.39063 article EN Arthritis & Rheumatology 2015-02-23

Matrix metalloproteinase (MMP)‐19 and MMP‐20 (enamelysin) are two recently discovered members of the MMP family. These enzymes involved in degradation various components extracellular matrix (ECM) during development, haemostasis pathological conditions. Whereas MMP‐19 mRNA is found widely expressed body tissues, including synovium normal rheumatoid arthritic patients, expression restricted to enamel organ. In this study we investigated ability cleave macromolecules characterising cartilage...

10.1016/s0014-5793(00)01819-6 article EN FEBS Letters 2000-07-24

A family of six insulin-like growth factor binding proteins (IGFBPs) bind IGF-I and modulate its biological activity. IGFBPs may to macromolecules on the cell surface or pericellular extracellular matrix, this interaction their effect IGF To date, little is known about specificity in regulation action brain. We therefore explored whether were associated with membrane matrix components rat sites characteristics an IGFBP found olfactory bulb mitral layer. This was identified as IGFBP-2 by...

10.1210/endo.138.11.5472 article EN Endocrinology 1997-11-01

Native and recombinant neutrophil collagenase (MMP-8) was shown to cleave at the E373-A374 'aggrecanase' site in interglobular domain of aggrecan. The time course digestion vitro showed that MMP-8 cleaved initially N341-F342, predominant metalloproteinase site, before cleaving site. A synthetic peptide, IPENFFG, inhibited cleavage but not N341-F342 vitro, indicating sequence a less preferred for than N341-F342. IPENFFG also release A374 RGSVI fragments from cartilage explant culture,...

10.1042/bj3040347 article EN Biochemical Journal 1994-12-01

Fragments of fibronectin occur naturally in vivo and are increased the synovial fluid arthritis patients. We have studied 45kDa fragment (Fn-f 45), representing N-terminal collagen-binding domain fibronectin, for its ability to modulate expression metalloproteinases by porcine articular chondrocytes vitro. report that stimulation cultured chondrocytes, or cartilage explants, with Fn-f 45 levels matrix metalloproteinase-13 (MMP-13; collagenase-3) released into conditioned medium a...

10.1042/bj3640181 article EN Biochemical Journal 2002-05-08
Coming Soon ...